Vol. 4 No. 1 (2023)

View Vol. 4 No. 1 (2023)

DOI: https://doi.org/10.17161/rrnmf.v4i1

Published: 2023-02-07

Full Issue

PDF

Letter from the Founding Facilitator

Letter from the Founding Facilitator for Volume 4, Issue 1

Richard J. Barohn, MD

1
- PDF

What’s on your Mind: Commentaries and Other Stuff (Letters to the Facilitators)

FDA should protect the American people, and Pharma should pay!

Joshua Freeman, MD

2-3
- PDF
Medicare Advantage - Whose Advantage Is It?

Donald Frey

4-5
- PDF

New Discoveries/New Stuff (Original Research)

Knowledge and perceptions of the COVID-19 pandemic among patients with myasthenia gravis: follow up survey

Yingkai Li, Yohei Harada, Marjan Cobbaert, Vern Juel, Lisa Hobson-Webb, Shruti Raja, Natalia Gonzalez, Jeffrey Guptill

6-13
- PDF
Emergent Comorbid Events in First Year of Immunomodulatory Treatment in Adults With Generalized Myasthenia Gravis treated in a Neurology Clinic: A Retrospective Review

Nakul Katyal MD, Brian Blankenship MD, Naureen Narula MD, Eric Grisham BAS, Raghav Govindarajan MD

14-19
- PDF
The Effects of Testosterone and Transcutaneous Muscle Stimulation on Strength and Muscle Mass in Myotonic Dystrophy

Salman Bhai MD, Alexis Lizarraga MD, Morgan McCreary PhD, Seth Kolkin MD, John Kissel MD, Richard J. Barohn MD

20-26
- PDF

Clinic Stuff (Case Reports)

A novel DOK7 mutation causing limb-girdle congenital myasthenic syndrome

Adam S. Reynolds MD, Ava Y. Lin MD, Leo H. Wang MD PhD

27-31
- PDF
Steroid Responsive Acute Inflammatory Demyelinating Polyneuropathy Induced by an Immune Check Point Inhibitor

Najwa Al-Bustani MD, Zulfiqar Hussain MD

32-33
- PDF
Non-5q Spinal Muscular Atrophy in a Patient With a Novel BICD2 Missense Variant

Nahee Park BS, Michael M. Muriello MD, Donald Basel MD, Caroline A. Kielczewski MS, Matthew Harmelink MD

34-41
- PDF

Meeting Stuff (Abstracts, Summaries, Photographs from meetings, & Posters)

2022 KCMD Symposium Abstracts

Various Authors

42-73
- PDF